Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

48257

registered interest
date	10/04/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the performance of cancer services against statements 11 and 12 in the National Institute for Health and Care Excellence Breast cancer quality standard.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	196367
answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to National Institute for Health and Care Excellence (NICE) Quality Standards. Commissioners should have regard to them in the planning of services they commission according to their population needs.</p><p> </p><p>Whilst no assessment has been made of the performance of services against the Breast Cancer Quality Standard, compliance with Quality Standards generally could be monitored through a range of mechanisms depending on the specific Quality Standard. For example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the Clinical Commissioning Group Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using Quality Standards where appropriate.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and Quality Standards. The new national clinical audit will be in place by the end of 2014-15.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196363 196365 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	3924 label Biography information for Yasmin Qureshi

48258

registered interest
date	10/04/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what methods of data collection his Department uses to measure the performance of services against each of the 13 statements in the National Institute for Health and Care Excellence Breast cancer quality standard.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	196365
answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to National Institute for Health and Care Excellence (NICE) Quality Standards. Commissioners should have regard to them in the planning of services they commission according to their population needs.</p><p> </p><p>Whilst no assessment has been made of the performance of services against the Breast Cancer Quality Standard, compliance with Quality Standards generally could be monitored through a range of mechanisms depending on the specific Quality Standard. For example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the Clinical Commissioning Group Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using Quality Standards where appropriate.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and Quality Standards. The new national clinical audit will be in place by the end of 2014-15.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196363 196367 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	3924 label Biography information for Yasmin Qureshi

48259

registered interest
date	10/04/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment his Department has made of the overall performance of cancer services against the National Institute for Health and Care Excellence Breast cancer quality standard.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	196363
answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Health and Social Care Act (2012) places a duty on NHS England to have regard to National Institute for Health and Care Excellence (NICE) Quality Standards. Commissioners should have regard to them in the planning of services they commission according to their population needs.</p><p> </p><p>Whilst no assessment has been made of the performance of services against the Breast Cancer Quality Standard, compliance with Quality Standards generally could be monitored through a range of mechanisms depending on the specific Quality Standard. For example, the 30 national clinical audits funded by NHS England, the Best Practice Tariff, Commissioning for Quality Improvement Initiatives arrangements and the Clinical Commissioning Group Outcome Indicator Set. These levers are designed to drive quality improvement in the National Health Service using Quality Standards where appropriate.</p><p> </p><p>At the request of NHS England, the Healthcare Quality Improvement Partnership will shortly begin commissioning a new national breast cancer clinical audit. There is an expectation that national clinical audits, where appropriate, support the implementation of NICE clinical guidelines and Quality Standards. The new national clinical audit will be in place by the end of 2014-15.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196365 196367 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	3924 label Biography information for Yasmin Qureshi

48261

registered interest
date	10/04/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that future iterations of the Cancer Patient Experience Survey enable the responses of patients with primary and secondary cancer to be analysed separately.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	196364
answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>No recent Ministerial discussions have taken place on the potential for Patient Reported Outcome Measures to be used to measure improvements in outcomes for breast cancer patients.</p><p><strong> </strong></p><p>NHS England took over responsibility for the Cancer Patient Experience Survey (CPES) on 1 April 2013. The development of the CPES is overseen by the Cancer Patient Experience Advisory Group (CPEAG), which has a wide ranging membership including clinicians, cancer charities, experts in survey methodologies, research bodies, health service commissioners and NHS England staff.</p><p> </p><p>The survey questionnaire is reviewed by CPEAG each year to ensure that it captures the best information and as part of the process for the next survey, NHS England is engaging with a range of stakeholders to look at how it can improve and amend the survey appropriately.</p><p> </p><p>In the meantime, NHS England has added a new question to the 2014 survey questionnaire to identify patients who have been diagnosed with cancer more than once because the evidence suggests that there may be a difference in the experience of those patients.</p><p> </p><p>The results of the 2014 survey will be published later this year.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196366 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	3924 label Biography information for Yasmin Qureshi

48262

registered interest
date	10/04/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions his Department has had on the potential for Patient Reported Outcome Measures to be used to measure improvements in outcomes for breast cancer patients.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	196366
answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>No recent Ministerial discussions have taken place on the potential for Patient Reported Outcome Measures to be used to measure improvements in outcomes for breast cancer patients.</p><p><strong> </strong></p><p>NHS England took over responsibility for the Cancer Patient Experience Survey (CPES) on 1 April 2013. The development of the CPES is overseen by the Cancer Patient Experience Advisory Group (CPEAG), which has a wide ranging membership including clinicians, cancer charities, experts in survey methodologies, research bodies, health service commissioners and NHS England staff.</p><p> </p><p>The survey questionnaire is reviewed by CPEAG each year to ensure that it captures the best information and as part of the process for the next survey, NHS England is engaging with a range of stakeholders to look at how it can improve and amend the survey appropriately.</p><p> </p><p>In the meantime, NHS England has added a new question to the 2014 survey questionnaire to identify patients who have been diagnosed with cancer more than once because the evidence suggests that there may be a difference in the experience of those patients.</p><p> </p><p>The results of the 2014 survey will be published later this year.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 196364 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
tabling member	3924 label Biography information for Yasmin Qureshi